Bristol-Myers Squibb Company (BMY)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	29,780,000	31,770,000	27,273,000	33,262,000	30,192,000
Total current liabilities	US$ in thousands	23,774,000	22,262,000	21,890,000	21,868,000	19,080,000
Current ratio		1.25	1.43	1.25	1.52	1.58

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $29,780,000K ÷ $23,774,000K
= 1.25

The current ratio of Bristol-Myers Squibb Company has shown some fluctuations over the past five years. As of December 31, 2020, the current ratio was 1.58, indicating that the company had $1.58 in current assets for every $1 in current liabilities.

However, by December 31, 2021, the current ratio decreased to 1.52, suggesting a slight weakening in the company's short-term liquidity position. This trend continued in 2022, with the current ratio further declining to 1.25.

In the following year, as of December 31, 2023, the current ratio improved to 1.43, indicating a positive shift towards a healthier liquidity position. Nonetheless, by December 31, 2024, the current ratio fell back to 1.25, signaling a potential concern as the company may have had slightly lesser current assets to cover its current liabilities.

Overall, Bristol-Myers Squibb Company's current ratio has varied over the past five years, showcasing both strengths and weaknesses in its short-term liquidity management. It is important for stakeholders to monitor these fluctuations to assess the company's ability to meet its short-term financial obligations.